Neuroscience of Psychedelics Workshop - Part 4/4

Franz Vollenweider details the neurological mechanisms underlying the therapeutic effects of psychedelics, particularly focusing on their influence on emotional processing and brain plasticity. Research indicates that substances like psilocybin and ketamine help regulate negative emotional biases in depressed patients by modulating brain networks that otherwise become hyperactive. These substances appear to facilitate the restoration of connectivity in regions associated with emotional self-regulation, such as the prefrontal cortex. Experimental data, including results from backward masking tasks and imaging studies, demonstrate that these compounds significantly impact how the brain processes emotional stimuli, specifically reducing responsiveness to negative inputs while enhancing neural signatures associated with emotional processing. Vollenweider explores the role of 5-HT2A and glutamate receptors in these pathways, highlighting the potential for targeted psychedelic-assisted interventions that leverage neuroplasticity to provide lasting improvements in mental health, distinct from the short-term effects of traditional antidepressants.